pharmacies must stop selling compounded semaglutide after may 2025 Compounding pharmacies to halt semaglutide sales May 22

On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding

28.98

★★★★☆4.8 (126)

Sales of Ozempic alternatives to change with end of weight-loss drug shortage

22.66

★★★★★4.9 (98)

Semaglutide injections will no longer be sold at compounding pharmacies after May 22

25.23

★★★★★5.0 (157)

Best Online Semaglutide Compounding Pharmacy: 5 Providers Compared (2026)

26.71

★★★★★4.7 (84)

The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made

28.70

★★★★★4.9 (203)

🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these

27.48

★★★★★5.0 (176)

Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots

20.08

★★★★★4.8 (132)